Denali Therapeutics Inc (DNLI) Insider Trading
- $4,950,000.00
- $330,759,685.79
- Oct. 18, 2024
- Ryan J Watts
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 23, 2022 | Director | 20,000 | $31.61 | Sell | $632,200.00 | |
Aug. 23, 2022 | Insider | 2,424 | $31.98 | Sell | $77,519.52 | |
Aug. 19, 2022 | CEO | 2,404 | $33.22 | Sell | $79,860.88 | |
Aug. 19, 2022 | Insider | 2,576 | $33.22 | Sell | $85,574.72 | |
Aug. 19, 2022 | Director | 2,253 | $33.22 | Sell | $74,844.66 | |
July 25, 2022 | Director | 20,000 | $35.61 | Sell | $712,200.00 | |
March 23, 2022 | Director | 20,000 | $33.83 | Sell | $676,600.00 | |
Feb. 11, 2022 | COO | 2,803 | $34.68 | Sell | $97,208.04 | |
Feb. 11, 2022 | CFO | 2,560 | $34.69 | Sell | $88,806.40 | |
Feb. 11, 2022 | CEO | 9,491 | $34.72 | Sell | $329,527.52 | |
Feb. 11, 2022 | Insider | 2,918 | $34.71 | Sell | $101,283.78 | |
Feb. 9, 2022 | COO | 1,423 | $37.10 | Sell | $52,793.30 | |
Feb. 9, 2022 | CFO | 1,296 | $37.09 | Sell | $48,068.64 | |
Feb. 9, 2022 | CEO | 2,719 | $37.55 | Sell | $102,098.45 | |
Jan. 5, 2022 | COO | 2,846 | $44.77 | Sell | $127,415.42 | |
Jan. 5, 2022 | Insider | 2,845 | $44.78 | Sell | $127,399.10 | |
Jan. 5, 2022 | CFO | 2,225 | $44.75 | Sell | $99,568.75 | |
Jan. 5, 2022 | CEO | 5,007 | $44.78 | Sell | $224,213.46 | |
Dec. 30, 2021 | Director | 20,047 | $45.36 | Sell | $909,331.92 | |
Dec. 28, 2021 | Director | 10,980 | $44.37 | Sell | $487,182.60 | |
Dec. 6, 2021 | COO | 10,000 | $42.27 | Sell | $422,700.00 | |
Dec. 6, 2021 | Insider | 1,476 | $42.52 | Sell | $62,759.52 | |
Dec. 1, 2021 | CEO | 18,333 | $44.92 | Sell | $823,518.36 | |
Nov. 10, 2021 | Director | 1,666 | $52.81 | Sell | $87,981.46 | |
Nov. 4, 2021 | COO | 10,000 | $52.84 | Sell | $528,400.00 | |
Oct. 4, 2021 | COO | 10,000 | $50.56 | Sell | $505,600.00 | |
Sept. 15, 2021 | Director | 1,666 | $53.40 | Sell | $88,964.40 | |
Sept. 7, 2021 | COO | 10,000 | $55.55 | Sell | $555,500.00 | |
Sept. 1, 2021 | CEO | 18,333 | $54.66 | Sell | $1,002,081.78 | |
Aug. 23, 2021 | Insider | 6,143 | $48.91 | Sell | $300,454.13 | |
Aug. 19, 2021 | CFO | 2,285 | $49.57 | Sell | $113,267.45 | |
Aug. 19, 2021 | COO | 2,544 | $49.60 | Sell | $126,182.40 | |
Aug. 19, 2021 | Insider | 2,546 | $49.58 | Sell | $126,230.68 | |
Aug. 19, 2021 | CEO | 2,376 | $49.57 | Sell | $117,778.32 | |
Aug. 18, 2021 | Director | 1,666 | $51.70 | Sell | $86,132.20 | |
Aug. 4, 2021 | COO | 10,000 | $52.22 | Sell | $522,200.00 | |
Aug. 2, 2021 | CEO | 18,333 | $51.41 | Sell | $942,499.53 | |
July 21, 2021 | Director | 1,666 | $65.13 | Sell | $108,506.58 | |
June 23, 2021 | Director | 1,666 | $70.74 | Sell | $117,852.84 | |
June 7, 2021 | Director | 94,378 | $70.35 | Sell | $6,639,492.30 | |
June 4, 2021 | COO | 10,000 | $64.55 | Sell | $645,500.00 | |
June 1, 2021 | CEO | 18,333 | $61.40 | Sell | $1,125,646.20 | |
May 26, 2021 | Director | 1,666 | $65.37 | Sell | $108,906.42 | |
May 24, 2021 | Director | 8,806 | $60.02 | Sell | $528,536.12 | |
May 21, 2021 | Director | 37,957 | $60.13 | Sell | $2,282,354.41 | |
May 4, 2021 | COO | 10,000 | $55.49 | Sell | $554,900.00 | |
April 28, 2021 | Director | 1,666 | $62.15 | Sell | $103,541.90 | |
April 5, 2021 | COO | 10,000 | $56.09 | Sell | $560,900.00 | |
April 1, 2021 | Director | 50,000 | $56.62 | Sell | $2,831,000.00 | |
April 1, 2021 | CEO | 18,334 | $56.60 | Sell | $1,037,704.40 |
Insiders are both buying and selling Denali Therapeutics Inc stock.
The insider traders at Denali Therapeutics Inc are: Ryan J Watts, Alexander O Schuth, Carole Ho, Steve E Krognes, Marc Tessier-Lavigne, Vicki L Sato, Douglas K Bratton, Alexander O. Schuth, Vicki L. Sato, Ryan J. Watts, Steve E. Krognes, David P Schenkein, Jennifer E Cook, and David P. Schenkein
The most active insider trader at Denali Therapeutics Inc is Ryan J Watts with 36 trades.
Douglas K Bratton has sold the most Denali Therapeutics Inc stock with a total value of $382,924,890.09.
Douglas K Bratton has bought the most Denali Therapeutics Inc stock with a total value of $9,900,000.00.
The most recent insider trade for Denali Therapeutics Inc was on Oct. 18, 2024.
The single biggest insider buy for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $4,950,000.00 on Dec. 12, 2017.
The single biggest insider sell for Denali Therapeutics Inc was from Douglas K Bratton with a total value of $144,091,870.00 on Feb. 12, 2021.